Johnson & Johnson recalling more Tylenol and other products
New York — Johnson & Johnson, citing lax cleaning procedures and other problems at a manufacturing plant at the center of massive recalls of nonprescription drugs such as Tylenol, said Friday that it was recalling tens of millions more bottles.
The company, whose reputation has been tarnished by the recalls, is recalling bottles and packages of various kinds of Tylenol, Benadryl, Rolaids and other consumer products, it said.
J&J said it completed an investigation of historical records dating to 2007 for products sold in the U.S. and produced by its McNeil consumer healthcare unit, which makes most of the recalled products.
The investigation found examples of insufficient equipment cleaning procedures, and instances where people failed to adequately document cleaning at McNeil’s Fort Washington, Pa., plant. J&J suspended production there in April.
McNeil also discovered one product for which the labeling did not include all the information that regulators required, J&J said.
The latest recall involved products affected by those issues, the company said, adding that it was “very unlikely†that this harmed product quality.
McNeil is conducting assessments at other sites that manufacture its products, which could lead to more product recalls, J&J said.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
